Xometry (NASDAQ:XMTR – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.11 EPS for the quarter, meeting analysts’ consensus estimates of $0.11, Briefing.com reports. Xometry had a negative return on equity of 6.79% and a negative net margin of 10.20%.The business had revenue of $180.72 million for the quarter, compared to the consensus estimate of $168.25 million. During the same quarter in the prior year, the business posted $0.02 EPS. The business’s revenue for the quarter was up 27.5% on a year-over-year basis. Xometry updated its Q4 2025 guidance to EPS.
Xometry Stock Performance
Xometry stock traded up $0.71 during mid-day trading on Wednesday, reaching $63.33. 576,214 shares of the company were exchanged, compared to its average volume of 721,962. Xometry has a twelve month low of $18.59 and a twelve month high of $63.52. The firm’s 50-day simple moving average is $50.96 and its two-hundred day simple moving average is $40.26. The company has a debt-to-equity ratio of 1.20, a quick ratio of 3.85 and a current ratio of 3.91. The firm has a market cap of $3.22 billion, a PE ratio of -51.49 and a beta of 0.87.
Analyst Upgrades and Downgrades
XMTR has been the subject of a number of research analyst reports. UBS Group upped their target price on Xometry from $35.00 to $40.00 and gave the company a “neutral” rating in a research report on Wednesday, August 6th. The Goldman Sachs Group upped their target price on Xometry from $49.00 to $56.00 and gave the company a “neutral” rating in a research report on Wednesday. Wedbush upped their target price on Xometry from $48.00 to $70.00 and gave the company an “outperform” rating in a research report on Wednesday. Citigroup reissued an “outperform” rating on shares of Xometry in a research report on Wednesday. Finally, Citizens Jmp upped their target price on Xometry from $65.00 to $75.00 and gave the company a “market outperform” rating in a research report on Wednesday. Six research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Xometry has an average rating of “Hold” and an average target price of $51.90.
Insider Buying and Selling
In related news, CFO James Miln sold 598 shares of Xometry stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $50.25, for a total value of $30,049.50. Following the transaction, the chief financial officer owned 144,115 shares in the company, valued at approximately $7,241,778.75. This trade represents a 0.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Randolph Altschuler sold 9,331 shares of Xometry stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $50.31, for a total value of $469,442.61. Following the completion of the transaction, the chief executive officer owned 310,271 shares in the company, valued at $15,609,734.01. The trade was a 2.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 9.66% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ameriprise Financial Inc. boosted its holdings in Xometry by 4.5% in the second quarter. Ameriprise Financial Inc. now owns 1,274,351 shares of the company’s stock valued at $43,060,000 after acquiring an additional 54,996 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Xometry by 26.6% in the first quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company’s stock valued at $11,281,000 after acquiring an additional 95,154 shares during the last quarter. Raymond James Financial Inc. lifted its stake in shares of Xometry by 0.5% during the second quarter. Raymond James Financial Inc. now owns 293,780 shares of the company’s stock worth $9,927,000 after purchasing an additional 1,453 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Xometry by 476.1% during the second quarter. Invesco Ltd. now owns 238,390 shares of the company’s stock worth $8,055,000 after purchasing an additional 197,013 shares in the last quarter. Finally, Squarepoint Ops LLC lifted its stake in shares of Xometry by 33.9% during the second quarter. Squarepoint Ops LLC now owns 183,799 shares of the company’s stock worth $6,211,000 after purchasing an additional 46,502 shares in the last quarter. Institutional investors and hedge funds own 97.31% of the company’s stock.
About Xometry
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
See Also
- Five stocks we like better than Xometry
- How to Start Investing in Real Estate
- Spotify Posts Huge EPS Beat: Shares Are Still Down Big From Highs
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Stardust’s Strategic Lithium Deal Could Be a Game-Changer
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Sticker Shock: Why Kimberly-Clark’s Sell-Off Is an Overreaction
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.
